283 related articles for article (PubMed ID: 34217367)
1. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
[TBL] [Abstract][Full Text] [Related]
2. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
3. Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy.
Klomjit N; Leung N; Fervenza F; Sethi S; Zand L
J Am Soc Nephrol; 2020 Oct; 31(10):2400-2411. PubMed ID: 32747354
[TBL] [Abstract][Full Text] [Related]
4. Types of M protein and clinicopathological profiles in patients with monoclonal gammopathy of renal significance.
Liang D; Liu J; Liang S; Xu F; Cheng Z; Huang X; Zeng C; Liu Z
J Nephrol; 2021 Aug; 34(4):1137-1146. PubMed ID: 32725498
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series.
Liu J; Liang D; Liang S; Xu F; Huang X; Jiang S; Hou J
Sci Rep; 2022 Oct; 12(1):16994. PubMed ID: 36216844
[TBL] [Abstract][Full Text] [Related]
6. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
7. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and clinical characteristics and outcome of monoclonal gammopathy of renal significance-related lesions in Latin America.
Peña C; Schutz NP; Riva E; Valjalo R; Majlis A; López-Vidal H; Lois V; Zamora D; Ochoa P; Shanley C; Gonzalez JT; Fantl D; Correa G; Ramirez J; Mur P; Silva G; Verri V; Rojas C; Escobar K; Glavic G; Méndez GP;
Nephrology (Carlton); 2020 Jun; 25(6):442-449. PubMed ID: 31825549
[TBL] [Abstract][Full Text] [Related]
9. Crystalglobulin-associated nephropathy presenting as MGRS in a case of monoclonal B-cell lymphocytosis: a case report.
Gupta RK; Arend LJ; Bk A; Narsipur S; Bhargava R
BMC Nephrol; 2020 May; 21(1):184. PubMed ID: 32423442
[TBL] [Abstract][Full Text] [Related]
10. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
11. The Role of Bone Marrow Biopsy Evaluation in the Workup for Monoclonal Gammopathy of Renal Significance: A Diagnosis of Exclusion.
Metcalf BD; Huang J; Kanaan HD; Abukhaled J; Li W; Samarapungavan D; Zarouk S; Zhang PL
Arch Pathol Lab Med; 2024 Mar; 148(3):e57-e62. PubMed ID: 37787408
[TBL] [Abstract][Full Text] [Related]
12. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS).
Niculae A; Peride I; Vinereanu V; Rădulescu D; Bratu OG; Geavlete BF; ChecheriŢă IA
Rom J Morphol Embryol; 2017; 58(3):1065-1068. PubMed ID: 29250691
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients.
Steiner N; Göbel G; Suchecki P; Prokop W; Neuwirt H; Gunsilius E
Oncotarget; 2018 Jan; 9(2):2344-2356. PubMed ID: 29416776
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy: The good, the bad and the ugly.
Glavey SV; Leung N
Blood Rev; 2016 May; 30(3):223-31. PubMed ID: 26732417
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of the clinical features of MGRS.
Du J; Hu Z
BMC Nephrol; 2024 Jan; 25(1):22. PubMed ID: 38229028
[TBL] [Abstract][Full Text] [Related]
20. [Paraprotein-related kidney disease. Experience in 22 cases].
Jerez J; Juanet C; Sharp J; Ernst D; Méndez GP; Sepúlveda RA
Rev Med Chil; 2020 Aug; 148(8):1059-1067. PubMed ID: 33399771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]